The words describe different goals
Topical describes where something is applied. Balms, creams, lotions and many gels fit that description. People often choose ordinary cannabis topicals hoping for comfort in a particular area, rather than a whole-body effect. Transdermal describes delivery through the skin into the bloodstream. A transdermal product is also applied topically, but its formulation is intended to move the ingredients farther.
The distinction is about delivery, not texture. A gel might be designed for local use or systemic absorption, and a patch-shaped product is not automatically a well-studied transdermal medicine. Ask what the maker actually claims and what testing supports that claim. If the package only says “infused,” that does not answer either question.
| Question | Ordinary topical product | Product designed for transdermal delivery |
|---|---|---|
| What is the intended purpose? | Often comfort at the area of application. | Delivery through the skin into circulation. |
| Does the shape settle the question? | No. Creams, balms and gels vary. | No. Read the formulation’s directions and evidence. |
| Can the jar amount be treated as an absorbed dose? | No. | No. |
| What should you check? | Ingredients, skin directions and a realistic local goal. | Those details plus systemic effects and medication considerations. |
Skin absorption depends on the formulation
Skin is a barrier, not an open doorway. Health Canada’s technical discussion explains that cannabinoid delivery across skin is challenging and depends on how a product is prepared. Simply mixing cannabis oil into a carrier does not demonstrate predictable absorption into the bloodstream.
A 2022 exploratory study measured CBD and THC in blood after healthy adults used a specific transdermal formulation. Participants did not report psychoactive effects in that study. Those findings show that systemic absorption is possible with that formulation, not that every cannabis cream behaves the same way or that every THC transdermal product is nonintoxicating. The study was open label and does not settle long-term safety or effectiveness.
For a consumer, the practical question is whether there is evidence about the actual product. “Absorbs deeply” is a marketing phrase unless the manufacturer can explain what was measured and how.
A large number on the jar is not a dose
Imagine a hypothetical balm labelled with 500 mg of CBD in the entire container. That number describes the container’s contents. It does not mean one application delivers 500 mg, and dividing the jar into portions still does not reveal the amount absorbed through your skin. This is a label example, not an application recommendation.
Look for whether cannabinoid amounts refer to the whole package, a measured portion or a concentration such as milligrams per gram. Also check whether the product contains THC. Our guide to milligrams versus percentages can help untangle the units, while reading labels and lab reports explains how to connect a label with the batch behind it.
Comparing two products by the biggest package number alone can be misleading when their container sizes and recommended applications differ.
What does the research say about relief?
Some people describe meaningful comfort from cannabis topicals, and those experiences deserve to be heard. They do not establish which ingredient caused the improvement or which conditions a product treats. The application itself, the carrier and other ingredients can all complicate that question.
In a 2024 randomized pilot trial, 40 people with established chemotherapy-induced neuropathy received CBD isolate cream or placebo before crossing over to the other cream. The studied CBD cream did not improve the measured neuropathy outcomes compared with placebo. That finding concerns a particular cream and condition; it does not prove that all topicals fail, but it does rule out treating that trial as a success story.
It is reasonable to be curious and careful at the same time. A useful claim identifies the formulation, the people studied and the outcome. Broad promises to repair nerves or cure arthritis go beyond what this example supports.
Read the whole ingredient list
Cannabis is only part of the product. A balm may also include fragrances, essential oils or other active ingredients. If you know that certain ingredients irritate your skin, their presence matters regardless of the cannabinoid content. Health Canada also describes the possibility of adverse skin reactions to cannabis-related exposures.
Follow the product’s labelled application directions. Do not put it in your mouth, eyes or on an open wound unless it is specifically intended for that use and your clinician agrees it is appropriate. Avoid improvising with extra heat, coverings or other ingredients to force greater absorption; those changes are not the labelled use.
If you develop a rash or worsening irritation, stop using it and ask a health professional about the reaction. New or unexplained pain deserves an assessment rather than repeated applications of a product whose purpose is uncertain.
Set a goal you can actually check
“My knee feels better” is a beginning. “I could stand comfortably long enough to wash the dishes” is more useful because it connects the experience with everyday function. Record what you applied, where you applied it and what changed. Include skin irritation or any unexpected whole-body effects, not just the improvement you hoped to see.
Change one thing at a time when possible. If you start a balm, change your exercise routine and switch pain medicines in the same week, you may notice improvement without knowing what contributed. Our article on tracking benefits and side effects offers a simple way to keep those observations together.
If a product is designed for transdermal absorption, bring the package to a pharmacist or clinician for a medication review. Being applied to the skin does not, by itself, establish that a product cannot affect the rest of the body.
Sources and further reading
- Varadi and colleagues, 2022: Human study of a specific transdermal CBD and THC formulation
- D’Andre and colleagues, 2024: Randomized trial of CBD cream for chemotherapy-induced neuropathy
- Health Canada: Cannabis and cannabinoids, topical absorption and skin reactions
- Health Canada: Reading a cannabis product label